These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 20211203)
21. Vaccine therapy of established tumors in the absence of autoimmunity. Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742 [TBL] [Abstract][Full Text] [Related]
22. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine. Huang Y; Fayad R; Smock A; Ullrich AM; Qiao L Cancer Res; 2005 Aug; 65(15):6990-9. PubMed ID: 16061685 [TBL] [Abstract][Full Text] [Related]
23. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model. Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857 [TBL] [Abstract][Full Text] [Related]
24. A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses. Conforti A; Peruzzi D; Giannetti P; Biondo A; Ciliberto G; La Monica N; Aurisicchio L J Immunother; 2009 Sep; 32(7):744-54. PubMed ID: 19561534 [TBL] [Abstract][Full Text] [Related]
25. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327 [TBL] [Abstract][Full Text] [Related]
26. Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma. Shibagaki N; Udey MC Eur J Immunol; 2003 Apr; 33(4):850-60. PubMed ID: 12672050 [TBL] [Abstract][Full Text] [Related]
27. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Ishida K; Primus FJ; Yamaue H Int J Cancer; 2007 Feb; 120(3):585-93. PubMed ID: 17096339 [TBL] [Abstract][Full Text] [Related]
28. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474 [TBL] [Abstract][Full Text] [Related]
29. Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine. Hangalapura BN; Oosterhoff D; de Groot J; Boon L; Tüting T; van den Eertwegh AJ; Gerritsen WR; van Beusechem VW; Pereboev A; Curiel DT; Scheper RJ; de Gruijl TD Cancer Res; 2011 Sep; 71(17):5827-37. PubMed ID: 21747119 [TBL] [Abstract][Full Text] [Related]
30. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245 [TBL] [Abstract][Full Text] [Related]